Paper Contents
Abstract
Microbial secondary metabolites are crucial sources of natural compounds, offering significant potential for therapeutic applications. There is considerable opportunity to discover new species of Streptomyces and novel compounds from this genus. With the ongoing rise in antibiotic resistance among pathogenic bacteria, there is an urgent need to isolate and discover new antibiotics and other drug agents. In line with this, actinomycetes are often targeted for the production of secondary metabolites and the evaluation of their therapeutic potential. Methods: A total of 15 pure isolates were examined
Copyright
Copyright © 2024 DR.SYED SHAHAB AHMAD. This is an open access article distributed under the Creative Commons Attribution License.
Paper ID:
IJPREMS40800006277
ISSN:
2321-9653
Publisher:
ijprems